Breast Care

Papers
(The median citation count of Breast Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Persistence to Adjuvant Endocrine Therapy for Breast Cancer in Botswana: An Observational Cohort Analysis65
Erratum40
Kombinationstherapie bei HER2+ mBC27
PharmaNews27
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?19
St. Gallen/Vienna 2025 Summary of Key Messages on Therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference18
Acknowledgement to Reviewers16
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study15
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience14
Front & Back Matter13
Effects and Risks of Hormonal Therapy before and after BC Therapy12
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation12
Front & Back Matter11
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis10
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients10
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database9
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study8
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases8
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)8
Sacituzumab govitecan: Trop-2 als Target7
The risk of cardiovascular disease following aromatase inhibitor therapy for breast cancer in postmenopausal women: a systematic review and meta-analysis7
Interview ABC7: Bridging the Gap7
Quality of Life in Patients Pre- and Post-Breast Reduction Surgery in a South African Population: A Single-Centred Patient-Based Study7
PharmaNews7
Using Virtual Therapy for Lymphedema and Disability Post-Mastectomy: Meta-Analysis with Systematic Review6
Quality of Life after Alloplastic versus Autologous Breast Reconstruction: The Influence of Patient Characteristics on Outcomes6
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue5
Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations5
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection5
Front & Back Matter5
Breast cancer related lymphedema: a common challenge among Nigerian breast cancer survivors5
Evolution of HER2 Targeting in Metastatic Breast Cancer5
Primary Prevention and Early Detection of Hereditary Breast Cancer4
Clinicopathological Factors Affecting Positive Margins after Breast-Conserving Surgery: A Comparative Study of Low- and High-Volume Hospitals4
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis4
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard4
Analysis of Lifestyle and Genetic Risk Factors in Urban Women in China Who Had Malignant or Suspected Malignant Breast Nodules Identified via Breast Cancer Screening4
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis4
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes4
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response4
Comparison of local recurrence outcomes between breast conservation therapy and mastectomy for the treatment of breast cancer among young women: A systematic review and meta-analysis4
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer3
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience3
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries3
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions3
Acknowledgement to Reviewers3
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts3
Revisiting the Need for Breast Imaging in Young Women with Clinically Significant Breast Pain and a Normal Physical Breast Examination3
Society Bulletins3
Expert Discussion: SABCS 20213
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”3
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati3
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy3
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience3
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty2
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey2
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium2
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients2
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20242
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus2
Insights from ASCO 20232
Biomarkers: Which Ones Do We Really Need Today?2
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?2
PharmaNews2
Front & Back Matter2
Impact of Levonorgestrel-Releasing Intrauterine Devices on Magnetic Resonance Imaging of the Breast2
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience2
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital2
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20252
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation2
Treatment Experience of Early-stage HR+, HER2− Breast Cancer in a Real-world Setting: European Patients’ Perspectives2
PharmaNews2
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level2
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data2
Evaluation of Interreader Agreement between Optimized Short and Full Breast MRI Protocols for Screening Breast Cancer in Moderate- and High-Risk Women2
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis2
PharmaNews1
Contents Vol. 17, 20221
PharmaNews1
ADC-basierte Therapie und Radiatio1
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts1
PharmaNews1
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies1
Contents Vol. 19, 20241
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer1
Acupuncture for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer: An Umbrella Review1
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer1
Impact of Therapy on Health-Related Quality of Life in Breast Cancer Patients >60 Years1
Phyllodes Tumor of the Breast: Histomorphological Transformation to High-Grade Tumor during Pregnancy and Challenging Oncoplastic Surgery1
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition1
Vitamin D and Breast Cancer Risk: Evaluating the Association and Effective Risk Reduction1
HER2-Low Breast Cancer: Where Are We?1
PharmaNews1
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review1
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy1
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?1
Front & Back Matter1
Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer1
Investigation of Risk Factors and Development and Validation of a Nomogram for Predicting Overall Survival in Breast-Invasive Lobular Carcinoma1
News from the San Antonio Breast Cancer Symposium 20221
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants1
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20231
Expert Discussion: ESMO 20241
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion1
Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy1
New Media Platforms for Teaching and Networking: Emerging Global Opportunities for Breast Surgeons1
PharmaNews0
Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience0
The Role of High Intensity Focused Ultrasound in the Treatment of Fibroadenomas: A Systematic Review0
Palbociclib: Neue 5-Jahres-OS-Daten aus RCT bei HR+/HER2– aBC0
PharmaNews0
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study0
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference0
Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis0
Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis0
Society Bulletins0
Granulomatous Mastitis Is Not as Benign as You Might Think: What Doctors Need to Know about the Lived Experience of People with This Rare Disease0
The Role of Social Media and Breast Cancer: How Does It Impact Patients?0
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer0
Microbial Biomarkers of Breast Tumor and Mastitis: Deciphering the Delicate Balance Between Potentially ‘Evil’ and ‘Benign’ Alliances in Mammary Microbiomes0
PharmaNews0
Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20230
Ärzt*in-Patient*in-Perspektive: Rezidivrisiko bei Brustkrebs0
Evaluation of Patient Satisfaction and Quality of Life Using the BREAST-Q Questionnaire in Oncoplastic Breast-Conserving Surgery Techniques for Centrally Located Breast Cancer0
Three-Fraction External Beam Radiotherapy in Patients with Early Breast Cancer0
CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis0
Erratum0
A Preliminary Study of Ultrasound-Guided Microwave Ablation for Nonpuerperal Mastitis Treatment0
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST)0
PharmaNews0
Breast cancer specialist training across Europe: A UEMS MJC Breast Care survey0
Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care0
Advanced Glycation End-Products: A Promising Prognostic Indicator in Breast Cancer Patients0
Lymph Node Pathologic Complete Response Rates in Breast Cancer Patients After Neoadjuvant Chemotherapy: Is Axillary Sampling Necessary?0
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature0
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20250
Prognostic Importance of Panimmune-Inflammation Value and PILE Scores in Non-Metastatic Luminal A Breast Cancer0
PharmaNews0
Sacituzumab Govitecan – hoch effektiv0
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-670
First-in-Class-Therapie mit Sacituzumab Govitecan0
App-Based Lifestyle Coaching (PINK!) Accompanying Breast Cancer Patients and Survivors to Reduce Psychological Distress and Fatigue and Improve Physical Activity: A Feasibility Pilot Study0
Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia0
Online Training to increase genetic and risk literacy in physicians counseling breast and ovarian cancer patients for genetic testing0
Fokus-Änderung auf HER2-Status beim mBC0
Ultrasound Measurement of the Distance between the Breast Tumor and the Skin: A Cut-Off Value for Safe Skin Preservation – Diagnostic Accuracy Study0
Patient Preferences for HR+/HER2− Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment0
Breast Augmentation with Autologous Fat Grafting Immediately after Removal of Polyacrylamide Hydrogel and Fibrotic Capsule in 162 Patients0
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer0
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer0
Patient Satisfaction, Esthetic Outcome, and Quality of Life in Oncoplastic and Reconstructive Breast Surgery: A Single Center Experience0
Acknowledgement to Reviewers0
Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification0
Mammakarzinom: Phesgo im häuslichen Umfeld0
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt0
Metastasierter Brustkrebs: Alles klar bei ADC?0
Erratum0
PharmaNews0
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 20180
Clinical Outcomes in Breast Cancer Patients with HER2-Positive, Node-Negative Tumors (≤3 cm)0
The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients0
Front & Back Matter0
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group0
Pyoderma Gangrenosum of the Breast: A Diagnostic Challenge0
The Role of Social Media in Breast Cancer Care and Survivorship: A Narrative Review0
Development and Validation of a Predictive Model for SLNB Exemption in DCIS Patients0
Front & Back Matter0
PharmaNews0
PharmaNews0
Do We Need Anthracyclines for Elderly Patients with Triple-Negative Breast Cancer?0
Brain metastases of a triple-negative breast cancer – A systematic literature review of the systemic treatment options0
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Muta0
Front & Back Matter0
Augmented Reality in Breast Surgery Education0
PharmaNews0
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences0
Routine Preoperative Nutritional Optimization Not Required in Patients Undergoing Breast Reconstruction0
Effects of Continuous Care Combined with Dietary Care on Sleep Quality and Quality of Life in Patients with Breast Cancer Fatigue0
Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20240
PharmaNews0
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study0
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer0
Breast-Conserving Surgery with Immediate Partial Breast Reconstruction by Using Pedicled Thoracodorsal Artery Perforator Flap: A 7-Year Follow-Up of 50 Women0
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment0
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?0
PharmaNews0
Expert Discussion: ASCO 20220
Gonadotropin-Releasing Hormone Agonists during Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients with Breast Cancer: A Systematic Review and Meta-0
Society Bulletins0
Distinct Immune Landscape and Gene Expression Profiles in Breast Cancer: Young vs. Non-Young Patients0
Evaluation of safety of elacestrant in patients with breast cancer: Insights from FDA adverse event reporting system database analysis0
Effect of Manual Acupoint Massage on Promoting Postpartum Milk Secretion in Cesarean Section Mothers: Randomized Clinical Trial0
Prognostic Impact of Immunophenotypic Variation in Subcapsular Sinus Endothelium of Sentinel Lymph Nodes in Invasive Breast Carcinoma0
ABC6 Consensus: Assessment by a Group of German Experts0
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer0
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20220
Axillary surgical management in breast cancer patients after neoadjuvant systemic therapy: a Delphi Study0
The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study0
A Decade of AGO QS-Mamma: Adherence to the Recommendations of the AGO Breast Committee for Diagnosis and Treatment in EBC in Routine Therapy in Germany0
PharmaNews0
PharmaNews0
Investigation of Factors Affecting Histopathological Upgrade in Breast Papillary Lesions: A Single-Center Study0
Magnetic Marker Artefacts on MRI and Localization Precision: Considerations for Targeted Axillary Dissection after Neoadjuvant Therapy0
What Has Changed in Patients Aged 65 and over Diagnosed with Breast Cancer during the COVID-19 Pandemic: A Single-Center Experience0
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients0
Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)0
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative R0
Management von Antikörper-Wirkstoff-Konjugaten bei mBC0
Risk and Survival of Third Primary Cancers in a Population-Based Cohort of Breast Cancer Patients0
ABC7 Consensus: Assessment by a German Group of Experts0
Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer0
Front & Back Matter0
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy0
A Response and Discussion with Respect to Gulcelik’s Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment0
Contents Vol. 18, 20230
Role of Sentinel Lymph Node Biopsy with Blue Dye Only after Neoadjuvant Systemic Treatment in Patients with Breast Cancer Who Had Biopsy-Proven Node-Positive Disease at Admission: SENATURK-ROSANNA Stu0
Expert Discussion: Hypofractionated Radiation Therapy – Standard for All Indications?0
A Second Ductoscopy Procedure in Patients with Recurrent and Persistent Pathological Nipple Discharge0
Current Evolutions in Axillary Management0
CDK4/6-Inhibitoren: Neue Daten vom ESMO und ASCO0
Budget Impact of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany0
Front & Back Matter0
New Perspectives in the Management of Triple-Negative Breast Cancer0
The Impact of Breast Awareness on the Early Detection of Breast Cancer in Young Women: A Systematic Review0
Evaluation of the Effect of Axillary Radiotherapy Dose and the Development of Lymphedema in Breast Cancer Patients0
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study0
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period0
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?0
Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab0
Clinicopathological features, surgical outcomes and microbial patterns in chronic granulomatous mastitis: A retrospective study from a public hospital in Lima, Peru.0
The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer0
PharmaNews0
Front & Back Matter0
Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report0
Breast Cancer Outcome: What Have We Achieved0
Should sonographic abnormal axillary lymph nodes be excised in sentinel node biopsy of breast cancer？0
Highlights from the San Antonio Breast Cancer Symposium 20240
Outcomes of breast cancer patients by race and ethnicity0
Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers0
Trastuzumab-Deruxtecan: Neue Ära bei HER2-low mBC0
Breast Cancer Surveillance of Young Israeli BRCA1/BRCA2 Pathogenic Sequence Variant Carriers: A Single-Institution Experience0
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging0
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20220
Erratum0
2.0738570690155